PaxMedica Statistics
Total Valuation
PaxMedica has a market cap or net worth of $1.90 million. The enterprise value is $271,394.
| Market Cap | 1.90M |
| Enterprise Value | 271,394 |
Important Dates
The last earnings date was Tuesday, May 14, 2024, after market close.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PaxMedica has 7.78 million shares outstanding. The number of shares has decreased by -41.30% in one year.
| Shares Outstanding | 7.78M |
| Shares Change (YoY) | -41.30% |
| Shares Change (QoQ) | -94.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.78% |
| Float | 6.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with zero debt.
| Current Ratio | 2.40 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 2.96 |
Financial Efficiency
Return on equity (ROE) is -1,525.13% and return on invested capital (ROIC) is -1,327.62%.
| Return on Equity (ROE) | -1,525.13% |
| Return on Assets (ROA) | -627.33% |
| Return on Capital (ROIC) | -1,327.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.59M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PaxMedica has paid $199,000 in taxes.
| Income Tax | 199,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -98.31% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 49.82 |
| Average Volume (20 Days) | 25,369 |
Short Selling Information
The latest short interest is 637,721, so 8.20% of the outstanding shares have been sold short.
| Short Interest | 637,721 |
| Short Previous Month | 133,720 |
| Short % of Shares Out | 8.20% |
| Short % of Float | 9.36% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.80M |
| Pretax Income | -18.15M |
| Net Income | -18.15M |
| EBITDA | -16.25M |
| EBIT | -27.12M |
| Earnings Per Share (EPS) | -$18.50 |
Balance Sheet
The company has $1.63 million in cash and no debt, giving a net cash position of $1.63 million or $0.21 per share.
| Cash & Cash Equivalents | 1.63M |
| Total Debt | n/a |
| Net Cash | 1.63M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 1.19M |
| Book Value Per Share | 0.15 |
| Working Capital | 1.69M |
Cash Flow
| Operating Cash Flow | -10.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.85M |
| FCF Per Share | -$24.87 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PaxMedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 41.30% |
| Shareholder Yield | 41.30% |
| Earnings Yield | -956.08% |
| FCF Yield | -571.76% |
Analyst Forecast
The average price target for PaxMedica is $3.00, which is 1,129.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 1,129.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 31, 2023. It was a reverse split with a ratio of 1:17.
| Last Split Date | Oct 31, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:17 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |